May 2023 - May 2024: responsible for business intelligence for Non-Retail focused portfolio (Oncology, Hematology and Rheumatology).June 2024 - today: responsible for business intelligence for Women’s Health portfolio. Additional qualifications: dunhumby analysis, price elasticity, trade marketing related analysis, such as national distribution of each SKU.

Business Intelligence partner of B2B Business Unit (non-retail market), including Oncology, Hematology and Rheumatology markets.- Responsible for analytical insights for markets and products performance, forecasting, non-retail database updates and support for brand plans, using Oncology Dynamics, INTE, NRC, PMB, Hospital Mapping databases from IQVIA, Globaldata, Market Research, Regulatory Intelligence reports and others. - Elaboration of competitive studies regarding other laboratories, considering their portfolio and trends.- Market Research Projects for the business unit, leading the entire process, from the briefing to results presentation.

• Responsible for supporting Amgen's Oncology in-line and pipeline, Bone Franchise (Osteoporosis and Bone Fracture) and Bergamo's pipeline.• Patient forecasting and sell-out of in-line and pipeline products, Amgen and Bergamo divisions, with knowledge in the respective therapeutic areas of these teams: Oncology (colorectal/ bone metastasis / neutropenia, Osteoporosis and Bone Fracture, Oncology Pipeline (NSCLC, Prostate cancer, and other indications related to specific biomarkers and mutations) and New Business Development - oncology and hospital indications.• Local implementation of a global forecasting tool - Anaplan/LIFT -, by leading meetings to prepare and orient market forecast based patient flow, regulatory surveys and market benchmarks.• Retail and Institutional market analysis.• Planning, monitoring and leadership of local and regional primary market research involving Brazil; Conduction of all stages of a market research, such as briefing elaboration considering product needs, proposal request, contact with Research Agency and Amgen's internal customer and areas involved.• Support Marketing teams for the preparation of Product Plans and forecasting reviews

- Management of the stablished commercial agreements.- Elaboration of an "Agreement Negotiation Tool" to support Amgen portfolio negotiation between sales team and clients (specific accounts and clinics).- Development of a weekly report of sell-out and inventory data provided by wholesalers reports.- Monthly report a forecast (preview) of sell-out with wholesalers data.- Analysis of wholesalers and important accounts sell-out with IQVIA MDTR and DDD Database.- Monthly report sell-in units and USD forecast of the month to Directors of BUs- Interaction with legal area for preparation and update of Distribution Contracts with wholesalers.- Support Customer Attendance Service (SAC) with business matters.

Gastrointestinals (GI) Category - Consumer Healthcare Brazil- Monthly Sell In / Sell Out / Days on Hand (DOH) projections for each GI product / SKU.- Elaboration of category presentations, focusing on subjects of Trade Marketing, Sales and Marketing teams interest.- Monitoring of GI products sell in, stock and sell out (units and value), with focus on top chains and wholesalers.- Analysis of GI products distribution in Brazil using IMS MDTR Data

- Market Analysis using IMS PMB and MIDAS Data- Analysis of molecules of interest for Generics BU portfolio, looking for therapeutical and market advantages over competitors - Sales Forecasts elaboration for new products based on market trends and medical, regulatory and marketing teams provided information- Preparation of Business Cases for new opportunities- Companies/Manufacturers portfolios evaluation identifying partnership opportunities